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African Animal Trypanosomiasis using
interventions targeted at cattle in Tororo
District; south-eastern Uganda
Dennis Muhanguzi1,2*, Walter O. Okello2, John D. Kabasa3, Charles Waiswa4, Susan C. Welburn2
and Alexandra P.M. Shaw2,5Abstract
Background: Tsetse-transmitted African trypanosomes cause both nagana (African animal Trypanosomiasis-AAT) and
sleeping sickness (human African Trypanosomiasis - HAT) across Sub-Saharan Africa. Vector control and chemotherapy
are the contemporary methods of tsetse and trypanosomiasis control in this region. In most African countries,
including Uganda, veterinary services have been decentralised and privatised. As a result, livestock keepers meet the
costs of most of these services. To be sustainable, AAT control programs need to tailor tsetse control to the inelastic
budgets of resource-poor small scale farmers. To guide the process of tsetse and AAT control toolkit selection, that
now, more than ever before, needs to optimise resources, the costs of different tsetse and trypanosomiasis control
options need to be determined.
Methods: A detailed costing of the restricted application protocol (RAP) for African trypanosomiasis control in Tororo
District was undertaken between June 2012 and December 2013. A full cost calculation approach was used; including
all overheads, delivery costs, depreciation and netting out transfer payments to calculate the economic (societal) cost
of the intervention. Calculations were undertaken in Microsoft Excel™ without incorporating probabilistic elements.
Results: The cost of delivering RAP to the project was US$ 6.89 per animal per year while that of 4 doses of a curative
trypanocide per animal per year was US$ 5.69. However, effective tsetse control does not require the application of
RAP to all animals. Protecting cattle from trypanosome infections by spraying 25 %, 50 % or 75 % of all cattle in a
village costs US$ 1.72, 3.45 and 5.17 per animal per year respectively. Alternatively, a year of a single dose of curative or
prophylactic trypanocide treatment plus 50 % RAP would cost US$ 4.87 and US$ 5.23 per animal per year. Pyrethroid
insecticides and trypanocides cost 22.4 and 39.1 % of the cost of RAP and chemotherapy respectively.
Conclusions: Cost analyses of low cost tsetse control options should include full delivery costs since they constitute
77.6 % of all project costs. The relatively low cost of RAP for AAT control and its collateral impact on tick control make
it an attractive option for livestock management by smallholder livestock keepers.
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African trypanosomes transmitted by tsetse flies (Diptera:
Glossinidae) cause human African trypanosomiasis (HAT)
and African animal trypanosomiasis (AAT), a debilitating
disease of domestic animals and humans in the humid and
sub-humid zones of Africa [1–4]. The tsetse-infested re-
gions of Uganda include regions where livestock constitute
the mainstay of livelihoods [5, 6]. Across much of this re-
gion, cattle are the main reservoir of human infective Try-
panosoma brucei (T.b) rhodesiense [7–9]. Uganda is unique
in that it has the human disease foci for both the chronic
form of HATcaused by T. b. gambiense and the acute form,
caused by T.b rhodesiense [9–12]. There is a serious risk of
a merger of the two forms of disease as a result of cattle
restocking following 20 years of unrest in the north and the
north-eastern parts of the country [10, 11, 13–15]. This
merger was arrested by a major intervention in 2006, the
Stamp-Out Sleeping Sickness (SOS) project, whose
objective was to remove infection from the major res-
ervoir of infection in cattle by chemoprophylaxis and
prevent reinfection by pyrethroid insecticide spraying
of about 0.5 million cattle in six districts bordering
Lake Kyoga [14, 16, 17].
Several tsetse and trypanosomiasis control methods
have been developed and applied individually or in com-
bination with varied levels of success in Uganda and
elsewhere. These include those targeted at the vector:
stationary baits [18–20], mobile baits (insecticide-treated
cattle) [16, 21, 22], aerial spraying [23, 24], sterile insect
technique (SIT) [25] and chemoprophylatic treatment of
cattle [26]. Before deployment of AAT control methods,
there is a need to evaluate both technical efficacy and
the cost of the control method to be deployed so that in-
formed choices can be made [27, 28].
In most African countries, veterinary services have
been decentralised and privatised. Uganda is no excep-
tion and as a result, livestock keepers meet the costs of
most of these services [29]. AAT control programs will
need to tailor tsetse control to livestock keepers’ budgets
to be sustainable [30]. The costs of different tsetse and
AAT control options are needed to guide the process,
aimed towards optimising resources [27, 28].
This study provides the first detailed economic costing
of applying the restricted insecticide application protocol
(RAP) for the control of tsetse and trypanosomiasis in
Tororo District, south-eastern Uganda. RAP involves the
application of pyrethroid insecticides on the tsetse predi-
lection sites of the animal (the legs and bellies) [30]. In
this study, deltamethrin (pyrethroid insecticide/acara-
cide), at dip concentration, was applied to the bellies,
fore and hind legs, the preferred feeding sites for G. f. fus-
cipes and G. pallidipes. Deltamethrin was also applied to
the ears of cattle, the usual predilection sites for Rhipice-
phalus appendiculatus ticks thus offering an additionalcollateral benefit of controlling T.parva, the infectious
agent that causes East Coast Fever [31], which is a major
constraint to livestock production and crop-livestock inte-
gration in this region [31–33]. The RAP costs provided
here contribute data to guide tsetse and trypanosomiasis
control programs. The values can be revised and contex-
tualised to guide future large-scale use of RAP for AAT
control programs.Methods
Study area
This study was carried out in Tororo District, south-eastern
Uganda (longitude 33.8–34.0; latitude 0.5–0.9) over a
period of 18 months between June 2012 and December
2013. The district is bordered by the districts of Mbale to
the north, Manafwa to the north-east, Busia to the south,
Bugiri to the south-west, Butaleja to the north-west and the
Republic of Kenya to the east. The district experiences two
wet seasons, from September to November and from
March to May. There are two dry seasons between June to
August and December to February. Cattle are the main tse-
tse hosts in Tororo district [7, 8] contributing up to 54 % of
all tsetse blood meals with the rest taken from pigs and
monitor lizards (Varanus niloticus) [8]. G. f. fuscipes and G.
pallidipes are the main tsetse fly species in the district [8].
There are localised foci of G. pallidipes especially in the
north-eastern parts of Tororo District linked to re-
introductions from Busia, Kenya [34]. Cattle in Tororo dis-
trict play a key role in providing animal traction [31, 32].Cattle population included in the cost analyses
This study was based on a recent trial carried out to op-
timise the restricted pyrethroid insecticide application
for simultaneous tsetse and tick-borne disease control
[31, 32, 35, 36]. Of the 22 intervention villages selected
from the 57 villages [31, 33], 12 villages were used to op-
timise RAP while the rest of the 10 villages were non-
RAP regimens (Fig. 1). An accumulated 1469 cattle were
sprayed in regimen 2, 3 and 4 representing 226, 545 and
698 cattle in each of the three RAP regimens respect-
ively. All animals in the 22 intervention villages were
tagged on introduction into the trial. To remove try-
panosomes already present from study cattle so as to
monitor the rate of reinfection during the 18 months of
the study, all cattle over 3 months of age (except for
those in 2 villages in regimen 6) were treated with
Veriben B12 (Ceva Santé Animale, France) - a trypano-
cide containing diminazene diaceturate, cyanocobalamin
(vitamin B12) and hydroxocobalamin (vitamin B12a) at a
dose of 0.01 g/kg live body weight by deep intramuscular
injection. Details of livestock keepers, their household
co-ordinates (village, parish, county) and their cattle
demographics (age, sex, breed,) were entered in a herd
Fig. 1 Study flow. Regimen 1: Diminazene diaceturate injections (DA); (0.01 g/kg body weight) forty days apart at the beginning of the trial. Regimen
2: DA and 25 % RAP. Regimen 3: DA and 50 % RAP. Regimen 4: DA and 75 % RAP. Regimen 5: DA and Albendazole 10 % drench (8 mg/kg body
weight) - 3 monthly for 18 months. Regimen 6: No treatment at all. Median time of follow up-FU (time difference between first and last sampling of
individual animals) was 12 months in each of the 6 treatment groups. The number in each of the regimens was arrived at by taking the average (taking
care of births, deaths, purchases and sales) number of cattle present in the regimen per month for the 18 month intervention period
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study, which was updated every three months [31, 36].
RAP was applied in twelve villages; three groups of
four villages that were allocated different regimes for
spraying fixed proportions (25, 50 and 75 %) of the total
village cattle herd [36]. An emulsifiable Deltamethrin
concentrate (Vectocid®, Ceva Interchem, Tunis) spray
was applied at dip concentration of 0.1 % deltamethrin
(1:1000; Vectocid to water parts) on the legs, bellies and
ears of cattle, every 28 days over 18 months. Three con-
trol groups were included in the study; 2 villages where
no interventions were undertaken; 4 villages where cattle
were only given two injections of a trypanocide forty
days apart at the beginning of the project and 4 villages
in which cattle were dewormed once every three
months. In all the villages (except those where no treat-
ment was administered) blood samples were taken four-
teen days after the second Veriben B12® treatment,
repeated at three monthly intervals to monitor trypano-
some and T.parva prevalences. In the two “no treatment
villages” blood was sampled on initial cattle tagging and
at 6 and 12 months. All cattle in the ten non-RAP vil-
lages were treated against trypanosomiasis on termin-
ation of the intervention either at 12 or 18 months, for
ethical reasons since they were at higher risk of acquir-
ing AAT.Inputs
Project implementation required inputs both at livestock
keeper and project levels. Inputs from the livestock
keepers included: movement of cattle to the cattle treat-
ment centres, provision of water for spraying, cattle
handling (e.g. ropes, crushes and physical labour) and
community mobilisation (by community heads or live-
stock keepers themselves). Inputs from the project inter-
vention side included Albafas® (Albendazole 10 %,
Norbrook Laboratories Ltd, Kenya), Vectocid® and Veri-
ben B12® bought in bulk from suppliers in Kampala.
Major capital expenses included acquiring and servicing
equipment like; spray pumps, a Hilux pick-up vehicle,
GPS units and a laptop computer. Consumables and re-
usable items included; ear-tag applicators and ear tags,
20 ml syringes for trypanocidal administration, needles,
syringes for de-wormer administration (50 ml), sterile
water for injection, protective clothing (examination
gloves, gum boots, face masks and overalls), assessment
tools such as Flinders Technology Associates (FTA)
cards, silica gel desiccants, capillary tubes, lancets, FTA
card pouches and office stationery. Communication, ve-
hicle (fuel, servicing and repairs), staff salaries and allow-
ances formed the bulk of recurrent expenses. For
analysis, these expenditures were categorised as capital
or recurrent expenditure. All inputs that were used in
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tle deworming, maintenance of the herd structure regis-
ter and principal investigators’ salaries are associated
with the research component of the project and were
treated independently in order to arrive at the costs at-
tributable to the control of trypanosomiasis (RAP with
and/or without curative trypanocide administration).
Economic analyses
The total or full cost calculation approach [27] was used
to undertake an economic rather than a financial ana-
lysis. In an organisational setting, initiating this type of
operation would require additional expenditure for vet-
erinary pharmaceuticals, taking of blood samples, staff
travel allowances and vehicle running costs. These vari-
able costs, often referred to as ‘direct’ are often the only
ones reported. A share of various overheads (fixed costs)
such as depreciation on capital items and a share of staff
salaries was added to these costs to calculate the full de-
livery cost. Cost calculations were undertaken using
Microsoft ExcelTM spreadsheets, without incorporating
probabilistic elements, since costs related to tsetse con-
trol programs vary with habitats, tsetse species, and or-
ganisational contexts rather than following a probability
distribution [27]. The analysis covered the 18 months of
the project to provide fair estimates of the value of all
inputs over that period, including those shared with
other activities and a share of any relevant overheads.
Depreciation on all capital items used was calculated
over the 18 month period using the straight line method,
based on estimated useful life and likely salvage value at
the end of that period, where relevant. To calculate the
economic (societal) cost of the intervention, transfer
payments (taxes) were netted out. Apart from this, mar-
ket prices were used without adjusting for externalities
and /or market distortions [27]. Opportunity costs of
cattle-keepers’ time were valued using appropriate prox-
ies, in this case the payment of a modest amount of US$
3.9 per village visit to the village head who would in turn
buy refreshments for the cattle owners and recover his
community mobilisation costs. A further study, based on
livestock keeper interviews, is investigating the cost to
livestock keepers. All costs are based on expenditure in
Uganda Shillings (UGX) or US$ at 2012/2013 prices. All
UGX are converted to US$ at the rate of UGX 2575 = 1
US$, which applies to the study period
(http://www.oanda.com/currency/historical-rates-classic).
Analyses were performed at three levels: i) full costs of
all the project activities indicating a share that was spent
on research, ii) costs of Veriben B12® injections, and
monthly RAP for 18 months and iii) costs of RAP only.
Costs of RAP delivery were calculated based on the
number (1469) of cattle sprayed. The costs of delivering
each group of activities were expressed per animal permonth (28 days). Direct costs including vehicle running
costs, Veriben B12® and Vectocid® were expressed as a
percentage of the overall total costs in each of the three
categories.
Ethical clearance
This study was reviewed by the Makerere University
College of Veterinary Medicine Animal Resources and
Biosecurity ethical review board for compliance to Ani-
mal use and Care Standards. It was then forwarded to
the Uganda National Council for Science and Technol-
ogy and approved under approval number HS1336.
Results
Costs of all project activities including biophysical
monitoring (research) for 18 months of follow-up
This component covers the full delivery costs from the
project side. These costs included those primarily related
to AAT control, namely application of RAP and Veriben
B12®. It also provides a detailed costing of activities for
monitoring project effectiveness (Trypanosoma spp. and
T.parva prevalences) that were not necessary for imple-
menting RAP or administering trypanocidal drugs.
These included blood sampling, cattle ear-tagging,
deworming, livestock keeper registration, updating the
herd structure register and a share of community mobil-
isation costs. The average number of animals present in
all 22 villages over the 18 month intervention period
was 4,691 head. The average number of animals in the
20 villages where RAP, chemotherapy and deworming
were undertaken was 4,309 head of which 1,469 in 12 of
the 20 villages received monthly RAP. In addition, 705
head in four villages were dewormed once three-
monthly for 18 months (Fig. 1). A summary of the costs
of the overall project over the 18-month intervention
period clearly indicating the cost that was spent on re-
search activities is presented in Table 1. Direct research
related activities constituted 55 % of all the project costs.
Costs of implementing monthly RAP for 18 months and
initial Veriben B12® injections
Four thousand, three hundred and nine (4309) cattle in
20 villages were injected with Veriben B12® intramuscu-
larly on introduction into the trial. This constituted a
major cost of this program implementation. An average
of 1,469 of the 4,309 cattle in 12 of the 20 villages was
sprayed, using RAP, once every 28 days. Table 2 presents
a summary of the costs of delivering RAP and Veriben
B12® intramuscular injections at the start of the trial.
Costs of delivering monthly RAP for 18 months
This section presents the cost of applying RAP to 1,469
cattle in 12 villages of Tororo District for 18 months at
intervals of 28 days. The total number sprayed over time
Table 1 Full cost of RAP, Veriben B12® injections, deworming and biophysical monitoring (research) for 18 months
Cost items Intervention
cost = X (US$)
Research
cost = Y (US$)
Total
cost = Z (US$)
X as % of
totala
Y as % of
totala
Z as % of
totala
A) Capital items
Specialised equipment (spray pumps) 583 0 583 0.4 0.0 0.4
Vehicle 2,200 300 2,500 1.4 0.2 1.6
Other equipment (laptop and GPS units) 66 0 66 0.0 0.0 0.0
Total capital 2,848 300 3,148 1.8 0.2 2.0
B) Recurrent expenditure
Spray pump service 450 0 450 0.3 0.0 0.3
Vectocid 3,402 0 3,402 2.1 0.0 2.1
Cattle ear tags and ear tag applicators 0 5,583 5,583 0.0 3.5 3.5
Protective gear (gloves, overalls,
masks and gumboots)
362 314 677 0.2 0.2 0.4
Trypanocidal injections (Veriben, needles,
syringes, injection water)
3,477 0 3,477 2.2 0.0 2.2
Albendazole 10 % and its administration syringes 1,437 0 1,437 0.9 0.0 0.9
Sample taking, packaging and postage
(capillary tubes, lancets, FTA cards and
pouches, silica gel desiccants and courier fees)
0 15,682 15,682 0.0 9.8 9.8
Stationery 0 1,400 1,400 0.0 0.9 0.9
Vehicle running and travel 8,758 1,194 9,953 5.5 0.8 6.2
Staff salaries 25,920 43,080 69,000 16.2 26.9 43.1
Staff travel allowances 24,418 17,444 41,862 15.3 10.9 26.2
Payments to village heads and communication 1,049 2,911 3,959 0.7 1.8 2.5
Total recurrent 69,273 87,609 156,881 43.3 54.8 98.0
C) Overall total 72,121 87,909 160,029a 45.1 54.9 100.0
Project cost per animal for 18 months (n:4,309) 16.7 20.4 37.1 45.1b 54.9b 100.0 b
Cost per animal per month 0.93 1.13 2.06 45.1c 54.9c 100.0c
aTotal Project Cost,bas a percentage of animal cost for 1.5 years, cas a percentage of animal cost per month
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exchanges, gifts and births. This required three animal
health providers (one veterinary surgeon and two live-
stock health assistants) working on average 8 days in a
month for 18 months to undertake community mobilisa-
tion or spraying of cattle. Table 3 shows the direct costs,
planning and organisational overheads that were in-
curred to maintain RAP for 18 months.
The annual cost of protecting cattle from trypanosome
infections using graded (25, 50 and 75 %) RAP
The unit cost of protecting cattle with graded RAP is
much lower than the unit cost of RAP per animal
sprayed. For example in the 4 villages containing 914
head of cattle only 229 cattle were sprayed to achieve a
25 % RAP coverage. This indicates that the annual unit
cost of protecting 914 cattle from trypanosome infec-
tions in the 25 % RAP coverage is US$ 1.72. This cost
increases to US$ 3.45 and 5.17 in the 50 % and 75 %
RAP coverage villages respectively (Table 4). These costsper regimen and their average (US$ 3.45) are actually
lower than the cost of RAP per animal sprayed for
18 months at US$ 10.34 (Table 3) or the equivalent of
US$ 6.89 per animal per year.
Discussion
This study analysed the costs incurred for applying RAP
to 1,409 cattle in 12 villages in Tororo District to assess
the applicability of RAP for AAT management in
small-scale livestock production systems. Trypanocidal
chemotherapy and RAP were targeted at AAT control.
Non-tsetse control activities related to monitoring project
effectiveness (Trypanosome species and T.parva preva-
lences) namely: blood sampling, herd structure records
and deworming, comprised 55 % of the costs. Such re-
search costs, together with administrative overheads often
account for a high proportion of the expenditure for AAT
control and vary greatly from strategy to strategy but are
often omitted from published cost figures for interven-
tions [37]. For technologies described as lower cost
Table 2 Costs of implementing monthly RAP for 18 months
and initial Veriben B12® injections
Cost items Total
(US$)
% of the
Total
A) Capital items
Specialised equipment (spray pumps) 583 1.0
Vehicle 1,900 3.2
Other equipment (laptop and GPS units) 65 0.1
Total capital 2,548 4.3
B) Recurrent expenditure
Trypanocidal injections (Veriben B12,
needles, syringes, injection water)
3,476 5.9
Vectocid 3,402 5.8
Spray pump service 450 0.8
Protective clothing (gloves, facemasks,
overalls, gumboots)
516 0.9
Payments to village heads and communication 912 1.5
Vehicle running and travel 7,564 12.8
Staff salaries 20,700 35.0
Staff travel allowances 19,519 33.0
Total recurrent 56,539 95.7
C) Overall total 59,087 100.0
RAP &Veriben B12 per individual animal for
18 months (n:4,309)
13.71 –
Cost per animal per month 0.76 –
Table 3 Costs of implementing monthly RAP for 18 months
Cost items Total (US$) % Total costs
A) Capital items
Specialised equipment (spray pumps) 583 3.8
Vehicle 800 5.3
Other equipment (laptop and GPS units) 65 0.4
Total 1,448 9.5
B) Recurrent expenditure
Spray pump service 450 3.0
Vectocid 3,402 22.4
Protective clothing for staff (gumboots,
overalls, gloves and facemasks)
241 1.6
Payment to village heads and
communication
295 1.9
Vehicle running and travel 3,185 21.0
Staff salaries 4,522 29.8
Staff travel allowances 1,648 10.8
Total recurrent 13,743 90.5
C) Overall total 15,191 100.0
Cost per individual animal for 18
months (n: 1,469)
10.34 –
Cost per animal per month 0.57 –
Table 4 The annual cost (US $) of protecting a cattle
population by spraying different proportions of the cattle
population using RAP
RAP
coverage
Cattle (n) Average sprayed Total RAP cost Annual cost
25 % 914 229 1,574.37 1.72
50 % 1,096 548 3,775.72 3.45
75 % 931 698 4,810.94 5.17
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has previously [27] been reported and confirmed here
(77.6 % of all costs) to be due to delivery. This cost is di-
vided between inputs by the veterinary or health services
of a specific project and the often, unquantified, inputs by
livestock keepers themselves. For this reason, the costs
calculated here for delivering RAP and preventive chemo-
therapy together or separately are slightly higher than
most of those previously reported.
Only a few studies on application of pour-on for tsetse
and trypanosomiasis control have attempted to include
both direct and indirect costs [38, 39]. Even then, these
studies looked at the use of pour-on which is often too
expensive for small-holder livestock keepers. Application
of pyrethroids using the pour-on methodology has been
reported to use 10 times the amount of insecticide/acar-
acide compared to RAP at dip concentration and risks
high pyrethroid environmental exposure [30, 40–42].
In this study, the full cost of applying pyrethroid insec-
ticides to the legs, bellies and ears is US$ 0.57 per ani-
mal per spray with the cost of the pyrethroid (in this
case Vectocid) representing 22.4 % (US$ 0.13) of all
costs. This cost is about twice the cost of US$ 0.25 (UK£
0.14) cited for 2005 in an earlier study [43]. That study
estimated that including delivery would approximately
increase total cost to tenfold that of the insecticide,comparable to the figure obtained here from detailed re-
cording of full costs. In that study an α-cypermethrin
formulation was used, which is generally cheaper than
the deltamethrin formulation used in this work to which
inflation (30 %) for Uganda during the period 2005–2013
would need to be added. In this study, unlike those in the
past [30, 43], the ears of cattle were sprayed to add an
additional benefit in the form of T.parva control which
further explains the higher cost figure obtained.
To estimate the current cost of delivery of a single
curative dose of Veriben B12®, the delivery costs per ani-
mal per month, excluding research supervision and all
costs related to deworming, spraying and injecting were
calculated using the data presented in Tables 1, 2 and 3
as US$ 0.79, 0.64 and 0.39 respectively. The average of
these three figures is US$ 0.61, which represents the full
cost of delivering an intervention using the same deliv-
ery structure as was developed for RAP. The cost of
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weight) and the cost of needles, syringes, sterile water
came to US$ 0.17 per animal. Thus the total cost for de-
livery of Veriben B12® was US$ 0.61and the total cost
per injection of Veriben was US$ 1.42. The cost of Iso-
metamidium chloride (Samorin®) is higher, at about US$
1.56 per 300 kg body weight dose, so approximately US$
1.00 per 192 kg bodyweight animal, which would come
to US$ 1.78, if delivery cost were added.
Comparing the cost to farmers of protecting their ani-
mals from trypanosomiasis using RAP or trypanocides is
not straightforward. As such, the two are not mutually
exclusive depending on the disease epidemiology in a
given area. In Tororo district for example, T. b rhode-
siense transmission rate was recently reported to be very
low with a district prevalence of about 0.03 % [35, 36].
On the other hand this area continues to have a signifi-
cant level of T.congolense and T.vivax transmission rates
which are rather hard to control compared to T. b rho-
desiense [35, 36]. Since AAT due to T.vivax and T.congo-
lense is still a major constraint to livestock production in
this area [35, 36], the proportion of cattle to be sprayed
would need to be increased to 50 % with a once-off
curative or prophylactic trypanocidal treatment per year
for 2–3 years to leverage AAT control [36, 44, 45]. Since
tsetse flies are more attracted to larger and older (often
more productive animals) animals in the herd than small
and younger animals [46], this category of cattle would
constitute the proportion of cattle to be sprayed. To le-
verage control of AAT due to T.congolense and T.vivax
whose population decay as a result of RAP alone is slow
[44, 45], all cattle in the district would in addition need
to be treated once per year with either a curative or
prophylactic trypanocide [36]. Trypanocidal treatments
would then be repeated for 2–3 years to provide a suffi-
cient HAT and AAT control regime. Curative and
prophylactic treatments would need to be alternated as a
sanative pair between years 2–3 in order to prevent the
likelihood of development of drug resistance against ei-
ther chemical [26, 47].
Integrating RAP usage with strategic trypanocide ad-
ministration explained above reduces over-dependence
on trypanocides; lowers the risk of drug resistance and
the cost of tsetse and tick-borne disease control with a
proportionate reduction in the risk of environmental
damage [31, 36, 48]. For example, Tororo District had
about 37,000 cattle at the time of this study. To maintain
all cattle in the district on RAP for a year, US$ 254,930
would be needed. If the interest was to control acute
HAT, only 25 % RAP coverage would be sufficient.
The unit cost of protecting cattle from trypanosome
infections would then be US$ 1.75 per animal per
year and would cost a quarter to half of the above
budget; US$ 63,733. A year of curative trypanocidaltreatment and 50 % RAP coverage would cost the farmers
in the district US$ 180,005 or US$ 4.87 per bovine while
that of prophylactic trypanocidal treatment and RAP
would cost US$ 193,325 or US$ 5.23 per bovine.
To protect cattle from trypanosome infections using
25, 50 and 75 % RAP coverages alone would cost US$
1.72, 3.45 and 5.17 per animal present per year (Table 4)
respectively which is much lower than the cost of main-
taining each animal on RAP per year (US$ 6.89). This is
because it has earlier been reported that spraying just a
proportion of a village cattle herd is sufficient for tsetse
and trypanosomiasis control [30, 36]. It is for this reason
that we ought to differentiate between the average cost
of RAP per animal sprayed per year and the average cost
of protecting cattle from trypanosome infections using dif-
ferent RAP herd coverage levels. It is here reported that
the latter cost is indeed much lower than the former.
Trypanocide application is the most popular approach
for trypanosomiasis control by livestock keepers in the
tsetse infested areas of Africa [26, 30, 49, 50]. Some 35
million doses were used in 2004 costing about US$ 30
million to the livestock industry [26]. Trypanocide use is
popular with livestock keepers because it is believed by
farmers to provide rapid, private and inexpensive means
of trypanosomiasis control compared to tsetse control
methods [30]. If farmers were to protect their cattle by
using trypanocides only, they would need to administer
some four or two doses of curative or prophylactic trypa-
nocides respectively, per animal per year. This is due to
the short window of protection afforded by curative trypa-
nocidal treatments compared to prophylactic trypanocides
[41]. As costed above, curative and prophylactic trypano-
cide treatments would cost them about US$ 5.69 (four
doses) and US$ 3.57 (2 doses) per animal per year respect-
ively. However, extensive use of trypanocides is threatened
with development of drug resistance [26, 47]. Moreover,
cattle that are produced under extensive trypanocide use
are less productive than those kept under low tsetse chal-
lenge by use of insecticides [41, 44, 45]. In addition, the
cost of chemotherapy is highly variable depending on
whether trypanocidal drugs are bought in bulk or in small
amounts, the expertise of the veterinary service provider,
and the distance from point of veterinary care. Small-
holder livestock keepers in Africa for example, keep a few
cattle (an average of 3 in Tororo) and procure trypano-
cides in small quantities at a higher price than project
drugs would be purchased in bulk from large wholesale
urban traders [41]. In this study, veterinary treatment
costs were shared by very many livestock keepers and
spread over a sizeable cattle population (4,309 head) indi-
cating that the cost to the farmer in Tororo could have
been higher.
The costs explained above should therefore be seen in re-
lation to the impact on the prevalences of Trypanosoma
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tion of ticks on cattle that maintains a small force of infec-
tion in the cattle population [30, 31]. Consequently, cattle
are exposed to a small population of ticks and therefore to
tick-borne infections. This is likely to promote and main-
tain endemic stability in the cattle population, a process by
which a large proportion of the herd is exposed to tick-
borne infections as calves and remain with a solid immun-
ity against similar infections as adults [31, 48, 51]. In
addition, RAP being a relatively low cost technology with
additional impact on TBDs together with the fact that it is
environmentally benign, have all been reported as some of
the collateral benefits of this technology [30, 40, 42, 52].
For these reasons, it has previously been suggested
[30, 40, 41] and is recommended here, that RAP be
adopted for simultaneous tsetse and tick-borne dis-
ease control in small holder crop-livestock produc-
tion systems.
For many AAT control programs, the bulk of the inter-
vention costs are for delivery and these need to be fully
quantified and included in future costing. In addition
costs related to project monitoring can also be substan-
tial and need to be teased apart from the costs of imple-
menting AAT control programs and quantified. Of all
the costs needed for this project’s implementation, 55 %
were related to project monitoring.Conclusions
This study showed that RAP could be delivered at US$
6.89 per animal per year which is comparable to the cost
of the delivery of four doses of curative trypanocide at
US$ 6.04 needed to keep cattle under high AAT trans-
mission areas like Tororo district. However, effective
tsetse control does not require the application of RAP to
all animals. Protecting cattle from trypanosome infec-
tions with 25 %, 50 % or 70 % RAP herd coverage would,
for example, cost US$ 1.72, 3.45 and 5.17 per head per
year respectively. Alternatively, a year of a single dose of
curative or prophylactic trypanocide treatment plus 50 %
RAP would cost US$ 4.87 and US$ 5.23 per animal per
year. Integrating strategic trypanocide usage and RAP
therefore provides cheaper and safer (reduced risk of
drug resistance and damage to non target organisms)
means for tsetse and trypanosomiasis control. For both
RAP and chemotherapy 77.6 and 60.9 % of costs were
for delivery; thus it is recommended that future cost
analyses, especially of low cost techniques, include a full
share of all overheads involved in delivery and project
preparation. The relatively low cost of RAP (US$ 0.57
per animal per spray; US$ 6.89 per animal per year) for
AAT control and its collateral impact on tick control
make it an attractive option for livestock management
by smallholder cattle keepers.Competing interests
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